202 related articles for article (PubMed ID: 19424414)
21. Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding.
Delphin C; Cahen P; Lawrence JJ; Baudier J
Eur J Biochem; 1994 Jul; 223(2):683-92. PubMed ID: 8055938
[TBL] [Abstract][Full Text] [Related]
22. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.
Ciribilli Y; Monti P; Bisio A; Nguyen HT; Ethayathulla AS; Ramos A; Foggetti G; Menichini P; Menendez D; Resnick MA; Viadiu H; Fronza G; Inga A
Nucleic Acids Res; 2013 Oct; 41(18):8637-53. PubMed ID: 23892287
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of DNA binding and in vitro transcriptional activities dependent on the C terminus of P53 proteins.
Kaku S; Albor A; Kulesz-Martin M
Biochem Biophys Res Commun; 2001 Jan; 280(1):204-11. PubMed ID: 11162500
[TBL] [Abstract][Full Text] [Related]
24. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.
Liu Q; Kaneko S; Yang L; Feldman RI; Nicosia SV; Chen J; Cheng JQ
J Biol Chem; 2004 Dec; 279(50):52175-82. PubMed ID: 15469940
[TBL] [Abstract][Full Text] [Related]
25. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
[TBL] [Abstract][Full Text] [Related]
26. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
27. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
28. Conformations of p53 response elements in solution deduced using site-directed spin labeling and Monte Carlo sampling.
Zhang X; Dantas Machado AC; Ding Y; Chen Y; Lu Y; Duan Y; Tham KW; Chen L; Rohs R; Qin PZ
Nucleic Acids Res; 2014 Feb; 42(4):2789-97. PubMed ID: 24293651
[TBL] [Abstract][Full Text] [Related]
29. The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.
Dornan D; Shimizu H; Burch L; Smith AJ; Hupp TR
Mol Cell Biol; 2003 Dec; 23(23):8846-61. PubMed ID: 14612423
[TBL] [Abstract][Full Text] [Related]
30. Mutation of conserved domain II alters the sequence specificity of DNA binding by the p53 protein.
Freeman J; Schmidt S; Scharer E; Iggo R
EMBO J; 1994 Nov; 13(22):5393-400. PubMed ID: 7957105
[TBL] [Abstract][Full Text] [Related]
31. Interactions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation.
Su D; Wang X; Campbell MR; Song L; Safi A; Crawford GE; Bell DA
PLoS Genet; 2015 Jan; 11(1):e1004885. PubMed ID: 25569532
[TBL] [Abstract][Full Text] [Related]
32. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells.
Lilling G; Elena N; Sidi Y; Bakhanashvili M
Oncogene; 2003 Jan; 22(2):233-45. PubMed ID: 12527892
[TBL] [Abstract][Full Text] [Related]
33. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
Di Como CJ; Prives C
Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
[TBL] [Abstract][Full Text] [Related]
34. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
[TBL] [Abstract][Full Text] [Related]
35. Regulation of DNA binding of p53 by its C-terminal domain.
Weinberg RL; Freund SM; Veprintsev DB; Bycroft M; Fersht AR
J Mol Biol; 2004 Sep; 342(3):801-11. PubMed ID: 15342238
[TBL] [Abstract][Full Text] [Related]
36. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
37. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.
Furlong EE; Rein T; Martin F
Mol Cell Biol; 1996 Oct; 16(10):5933-45. PubMed ID: 8816507
[TBL] [Abstract][Full Text] [Related]
38. The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein.
Brázda V; Čechová J; Battistin M; Coufal J; Jagelská EB; Raimondi I; Inga A
Biochem Biophys Res Commun; 2017 Jan; 483(1):516-521. PubMed ID: 28007599
[TBL] [Abstract][Full Text] [Related]
39. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
Marks J; Saifudeen Z; Dipp S; El-Dahr SS
J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
[TBL] [Abstract][Full Text] [Related]
40. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
Kubicka S; Trautwein C; Niehof M; Manns M
Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
